Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


04.09.2017

6 Ann Thorac Surg
1 Anticancer Res
5 BMC Cancer
5 Br J Cancer
1 Cancer
1 Cancer Sci
1 Chest
1 Clin Cancer Res
1 Clin Lung Cancer
1 Eur J Cancer
1 J Cancer Res Clin Oncol
3 J Clin Oncol
3 J Thorac Oncol
2 Lancet
2 Lung Cancer (Auckl)
1 Mol Cancer Ther
1 N Engl J Med
2 Oncol Rep
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Thorac Surg

  1. KONNO H, Saito H, Nanjo H, Hiroshima Y, et al
    Rapid Immunohistochemistry With Thyroid Transcription Factor-1 for Pulmonary Adenocarcinoma.
    Ann Thorac Surg. 2017;104:471-476.
    PubMed     Text format     Abstract available

  2. THOMAS DC, Blasberg JD, Arnold BN, Rosen JE, et al
    Validating the Thoracic Revised Cardiac Risk Index Following Lung Resection.
    Ann Thorac Surg. 2017;104:389-394.
    PubMed     Text format     Abstract available

  3. BOWLING MR, Brown C, Anciano CJ
    Feasibility and Safety of the Transbronchial Access Tool for Peripheral Pulmonary Nodule and Mass.
    Ann Thorac Surg. 2017;104:443-449.
    PubMed     Text format     Abstract available

  4. ROLLI L, Leuzzi G, Girotti P, Duranti L, et al
    Permeable Nonabsorbable Mesh for Total Diaphragmatic Replacement in Extended Pneumonectomy.
    Ann Thorac Surg. 2017;104:e105-e107.
    PubMed     Text format     Abstract available

  5. SHINOHARA S, Yamada T, Ueda M, Ishinagi H, et al
    Phrenic Nerve Reconstruction and Bilateral Diaphragm Plication After Lobectomy.
    Ann Thorac Surg. 2017;104:e9-e11.
    PubMed     Text format     Abstract available

  6. BAKIA JM, Retera JMAM, van Ieperen RP, de Winter RJ, et al
    Plication of the Diaphragm in Postpneumectomy Right-to-Left Shunting.
    Ann Thorac Surg. 2017;104:e181-e183.
    PubMed     Text format     Abstract available


    Anticancer Res

  7. MARIAMPILLAI AI, Cruz JPD, Suh J, Sivapiragasam A, et al
    Cancer Antigen 72-4 for the Monitoring of Advanced Tumors of the Gastrointestinal Tract, Lung, Breast and Ovaries.
    Anticancer Res. 2017;37:3649-3656.
    PubMed     Text format     Abstract available


    BMC Cancer

  8. PARK SM, Lee J, Kim YA, Chang YJ, et al
    Factors related with colorectal and stomach cancer screening practice among disease-free lung cancer survivors in Korea.
    BMC Cancer. 2017;17:600.
    PubMed     Text format     Abstract available

  9. WANG X, Su S, Li S, Bao H, et al
    Development of quality indicators for non-small cell lung cancer care: a first step toward assessing and improving quality of cancer care in China.
    BMC Cancer. 2017;17:603.
    PubMed     Text format     Abstract available

  10. HATA Y, Kiribayashi T, Kishi K, Nagashima M, et al
    Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: a multicenter randomized controlled trial.
    BMC Cancer. 2017;17:581.
    PubMed     Text format     Abstract available

  11. NAITO T, Okayama T, Aoyama T, Ohashi T, et al
    Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non-small-cell lung cancer.
    BMC Cancer. 2017;17:571.
    PubMed     Text format     Abstract available

  12. AARELEID T, Zimmermann ML, Baburin A, Innos K, et al
    Divergent trends in lung cancer incidence by gender, age and histological type in Estonia: a nationwide population-based study.
    BMC Cancer. 2017;17:596.
    PubMed     Text format     Abstract available


    Br J Cancer

  13. PEDERSEN AB, Horvath-Puho E, Ehrenstein V, Rorth M, et al
    Frozen shoulder and risk of cancer: a population-based cohort study.
    Br J Cancer. 2017;117:144-147.
    PubMed     Text format     Abstract available

  14. CHERNYAVSKIY P, Edmondson EF, Weil MM, Little MP, et al
    High-energy particle beam and gamma radiation exposure, familial relatedness and cancer in mice.
    Br J Cancer. 2017;117:41-50.
    PubMed     Text format     Abstract available

  15. WEISS GJ, Waypa J, Blaydorn L, Coats J, et al
    A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus).
    Br J Cancer. 2017;117:33-40.
    PubMed     Text format     Abstract available

  16. LI M, Yang J, Zhou W, Ren Y, et al
    Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer.
    Br J Cancer. 2017 Aug 29. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available

  17. SAMARENDRA H, Jones K, Petrinic T, Silva MA, et al
    A meta-analysis of CXCL12 expression for cancer prognosis.
    Br J Cancer. 2017;117:124-135.
    PubMed     Text format     Abstract available


    Cancer

  18. BAUM JE, Zhang P, Hoda RS, Geraghty B, et al
    Accuracy of next-generation sequencing for the identification of clinically relevant variants in cytology smears in lung adenocarcinoma.
    Cancer. 2017;125:398-406.
    PubMed     Text format     Abstract available


    Cancer Sci

  19. KUTKOWSKA J, Strzadala L, Rapak A
    Synergistic activity of sorafenib and betulinic acid against clonogenic activity of non-small cell lung cancer cells.
    Cancer Sci. 2017 Aug 28. doi: 10.1111/cas.13386.
    PubMed     Text format     Abstract available


    Chest

  20. DATTA D, Yap V
    A Woman in Her 50s With a Mass in One Lung and a Cavitary Lesion in the Other.
    Chest. 2017;152:e15-e19.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  21. OOKI A, Maleki Z, Tsay JJ, Goparaju CM, et al
    A panel of novel detection and prognostic methylated DNA markers in primary non-small cell lung cancer and serum DNA.
    Clin Cancer Res. 2017 Aug 29. pii: clincanres.1222.2017.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  22. BROSSEAU S, Gounant V, Naltet C, Theou-Anton N, et al
    Lazarus Syndrome With Crizotinib in a Non-Small Cell Lung Cancer Patient With ROS1 Rearrangement and Disseminated Intravascular Coagulation.
    Clin Lung Cancer. 2017 Aug 3. pii: S1525-7304(17)30211.
    PubMed     Text format    


    Eur J Cancer

  23. SABRKHANY S, Kuijpers MJE, van Kuijk SMJ, Sanders L, et al
    A combination of platelet features allows detection of early-stage cancer.
    Eur J Cancer. 2017;80:5-13.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  24. TANG JL, Hou CJ
    Commentary on: undertreatment trend in elderly lung cancer patients in Brazil.
    J Cancer Res Clin Oncol. 2017 Aug 29. doi: 10.1007/s00432-017-2498.
    PubMed     Text format    


    J Clin Oncol

  25. GOVINDAN R, Szczesna A, Ahn MJ, Schneider CP, et al
    Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2017 Aug 30:JCO2016717629. doi: 10.1200/JCO.2016.71.7629.
    PubMed     Text format     Abstract available

  26. KAMDAR MK, Smith SM
    Extranodal Marginal Zone Lymphoma: No Longer Just a Sidekick.
    J Clin Oncol. 2017 Apr 27:JCO2017722835. doi: 10.1200/JCO.2017.72.2835.
    PubMed     Text format     Abstract available

  27. BURRIS HA, Infante JR, Ansell SM, Nemunaitis JJ, et al
    Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors.
    J Clin Oncol. 2017;35:2028-2036.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  28. ARULANANDA S, Do H, Musafer A, Mitchell P, et al
    Combination osimertinib and gefitinib in C797S and T790M EGFR mutated non-small-cell lung cancer.
    J Thorac Oncol. 2017 Aug 23. pii: S1556-0864(17)30681.
    PubMed     Text format     Abstract available

  29. WALD P, Mo X, Barney C, Gunderson D, et al
    Prognostic value of primary tumor volume changes on kV-CBCT during definitive chemoradiotherapy for stage III non-small cell lung cancer.
    J Thorac Oncol. 2017 Aug 23. pii: S1556-0864(17)30685.
    PubMed     Text format     Abstract available

  30. DAVID EA, Clark JM, Cooke DT, Melnikow J, et al
    The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non-small Cell Lung Cancer.
    J Thorac Oncol. 2017 Aug 23. pii: S1556-0864(17)30683.
    PubMed     Text format     Abstract available


    Lancet

  31. JENKINS BJ
    Potential efficacy of interleukin-1beta inhibition in lung cancer.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32289.
    PubMed     Text format    

  32. RIDKER PM, MacFadyen JG, Thuren T, Everett BM, et al
    Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32247.
    PubMed     Text format     Abstract available


    Lung Cancer (Auckl)

  33. SANTARPIA M, Liguori A, Karachaliou N, Gonzalez-Cao M, et al
    Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy.
    Lung Cancer (Auckl). 2017;8:109-125.
    PubMed     Text format     Abstract available

  34. SPYRATOS D, Papadaki E, Lampaki S, Kontakiotis T, et al
    Chronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges.
    Lung Cancer (Auckl). 2017;8:101-107.
    PubMed     Text format     Abstract available


    Mol Cancer Ther

  35. AKENO N, Reece AL, Callahan M, Miller AL, et al
    Trp53 Mutants Drive Neuroendocrine Lung Cancer through Loss-of-Function Mechanisms with Gain-of-Function Effects on Chemotherapy Response.
    Mol Cancer Ther. 2017 Aug 28. pii: molcanther.0353.2017.
    PubMed     Text format     Abstract available


    N Engl J Med

  36. RECK M, Rabe KF
    Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer.
    N Engl J Med. 2017;377:849-861.
    PubMed     Text format    


    Oncol Rep

  37. FUNAKI S, Shintani Y, Kawamura T, Kanzaki R, et al
    Chemotherapy enhances programmed cell death 1/ligand 1 expression via TGF-beta induced epithelial mesenchymal transition in non-small cell lung cancer.
    Oncol Rep. 2017 Aug 9. doi: 10.3892/or.2017.5894.
    PubMed     Text format     Abstract available

  38. KONG R, Liu W, Guo Y, Feng J, et al
    Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer.
    Oncol Rep. 2017 Aug 28. doi: 10.3892/or.2017.5927.
    PubMed     Text format     Abstract available


    PLoS One

  39. PUNIA R, Raina K, Agarwal R, Singh RP, et al
    Acacetin enhances the therapeutic efficacy of doxorubicin in non-small-cell lung carcinoma cells.
    PLoS One. 2017;12:e0182870.
    PubMed     Text format     Abstract available

  40. VAN DER WEKKEN AJ, Kuiper JL, Saber A, Terpstra MM, et al
    Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression.
    PLoS One. 2017;12:e0182885.
    PubMed     Text format     Abstract available

  41. HSU MK, Lin HY, Chen FC
    NMD Classifier: A reliable and systematic classification tool for nonsense-mediated decay events.
    PLoS One. 2017;12:e0174798.
    PubMed     Text format     Abstract available

  42. PARK JE, Chun SE, Reichel D, Min JS, et al
    Polymer micelle formulation for the proteasome inhibitor drug carfilzomib: Anticancer efficacy and pharmacokinetic studies in mice.
    PLoS One. 2017;12:e0173247.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: